首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cns & neurological disorders-drug targets

缩写:CNS NEUROL DISORD-DR

ISSN:1871-5273

e-ISSN:1996-3181

IF/分区:3.3/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1974条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yash Kalra,Shikha Baghel Chauhan,Indu Singh et al. Yash Kalra et al.
A revolutionary method for targeted neurotherapeutics is focused ultrasound (FUS)-mediated blood-brain barrier (BBB) regulation. In order to enable controlled and targeted intracerebral drug delivery, recent developments in hybrid extracell...
Yimin Yang,Jianxing Guo,Guowei Ye et al. Yimin Yang et al.
Spinal cord injury (SCI) leads to severe sensory, motor, and autonomic dysfunction with limited treatment options. Ginsenosides, the primary bioactive compounds derived from Panax ginseng, have demonstrated neuroprotective potential in SCI....
N Pavithra,Rukaiah Fatma Begum,S Thanga Ashwini et al. N Pavithra et al.
Parkinson's disease (PD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), and spinocerebellar ataxias (SCAs) are examples of neurodegenerative disorders (NDDs) that share overlapping neuropathological processes and largely a...
V Rajeshwar,C Ronald Darwin,K Ilango et al. V Rajeshwar et al.
The global health burden is attributed to neurodegenerative diseases, of which Alzheimer's disease and Parkinson's disease represent the major NDs. Changes in the blood-brain barrier system are considered an important mechanism in the patho...
Kiana Mohammadian,Tahereh Kalantari,Rasoul Ebrahimi et al. Kiana Mohammadian et al.
Introduction: Inflammatory and coagulation pathways are crucial in the pathogenesis and clinical progression of ischemic stroke. The objective of this study was to evaluate serum concentrations of interleukin-2 (IL-2) and...
Mohammad Yasin Zamanian,Olga F Belaia,Zhanna R Gardanova Mohammad Yasin Zamanian
Alzheimer's disease (AD) is marked by progressive cognitive decline and memory loss. Emerging evidence underscores the role of long non-coding RNAs (lncRNAs), particularly nuclearenriched abundant transcript 1 (NEAT1), in AD pathogenesis. N...
Vaishali Kaushal,Abdul Hafeez,Shazia Afzal Usmani et al. Vaishali Kaushal et al.
The blood-brain barrier (BBB) restricts the passage of drugs into the brain, preventing drug transport to the central nervous system and minimizing the therapeutic effectiveness of several drugs used for brain diseases. The intranasal route...
Sudharshanan Jothi Venkatesan,Meghana Devraj,Mallesh Gowda Virupakshappa et al. Sudharshanan Jothi Venkatesan et al.
Alzheimer's Disease (AD) is a progressive neurodegenerative condition, which is typified by the extracellular presence of amyloid-B (A2) in the form of plaques, intracellular neurofibrillary tangles, which are made up of hyperphosphorylated...
Xiangning He,Xunlu Yin,Qian Chen et al. Xiangning He et al.
In recent years, the cGAS-STING signaling pathway has emerged as a highly regarded mechanism for intracellular DNA recognition and innate immune activation. This pathway activates downstream interferon and inflammatory factor expression by ...
Saloni Sharma,Devkant Sharma,Anjali Sharma Saloni Sharma
Introduction: Vascular dementia is a leading cause of cognitive deterioration worldwide, caused by a complex interplay of pathological mechanisms such as disrupted cerebral blood flow, oxidative stress, neuroinflammation,...